A-Bec (Abacavir)
A-Bec (Abacavir) | Variation | Price | Price / Unit | Quantity | Add To Cart |
---|---|---|---|---|
30 Tablet/s | $105.00 | $3.5/ Piece | ||
60 Tablet/s | $204.00 | $3.4/ Piece | ||
90 Tablet/s | $297.00 | $3.3/ Piece |
Abacavir is an antiretroviral medication used in the treatment of human immunodeficiency virus (HIV) infection.
Active Ingredient (Generic Name): | Abacavir |
Manufacturer: | Emcure Pharmaceuticals Ltd. |
Packaging: | 30 Tablets in bottle |
Strength: | 300 MG |
Delivery Time: | 6 To 15 days |
SKU: | A-Bec (Abacavir) |
Description
Product details
Quantity Value |
30 Tablet/s ,60 Tablet/s ,90 Tablet/s |
---|
Customer Reviews
Rated 0 out of 5
0 reviews
Rated 5 out of 5
0
Rated 4 out of 5
0
Rated 3 out of 5
0
Rated 2 out of 5
0
Rated 1 out of 5
0
Be the first to review “A-Bec (Abacavir)” Cancel reply
Related Products
$136.00 – $391.00
Select options
This product has multiple variants. The options may be chosen on the product page
$168.00 – $487.00
Select options
This product has multiple variants. The options may be chosen on the product page
$250.00 – $690.00
Select options
This product has multiple variants. The options may be chosen on the product page
$75.00 – $180.00
Select options
This product has multiple variants. The options may be chosen on the product page
$200.00 – $1,700.00
Select options
This product has multiple variants. The options may be chosen on the product page
$60.00 – $162.00
Select options
This product has multiple variants. The options may be chosen on the product page
$150.00 – $428.00
Select options
This product has multiple variants. The options may be chosen on the product page
$300.00 – $878.00
Select options
This product has multiple variants. The options may be chosen on the product page
$90.00 – $252.00
Select options
This product has multiple variants. The options may be chosen on the product page
$90.00 – $240.00
Select options
This product has multiple variants. The options may be chosen on the product page
Reviews
Clear filtersThere are no reviews yet.